G01N 33/5761
Hepatitis b
Official title: {Hepatitis B}
G01N33/5761 (Hepatitis b) appears on 127 US grants and 122 published applications in this corpus.
Search patents in G01N- Granted patents
- 127
- Published applications
- 122
- Assignees
- 126
- Inventors
- 462
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 2 | 0 |
| 1979 | 0 | 0 |
| 1980 | 6 | 0 |
| 1981 | 0 | 0 |
| 1982 | 1 | 0 |
| 1983 | 1 | 0 |
| 1984 | 2 | 0 |
| 1985 | 0 | 0 |
| 1986 | 4 | 0 |
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 5 | 0 |
| 1990 | 4 | 0 |
| 1991 | 5 | 0 |
| 1992 | 8 | 0 |
| 1993 | 5 | 0 |
| 1994 | 4 | 0 |
| 1995 | 1 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 2 |
| 2002 | 1 | 3 |
| 2003 | 0 | 3 |
| 2004 | 1 | 4 |
| 2005 | 0 | 3 |
| 2006 | 3 | 4 |
| 2007 | 2 | 6 |
| 2008 | 2 | 6 |
| 2009 | 2 | 5 |
| 2010 | 2 | 9 |
| 2011 | 2 | 1 |
| 2012 | 2 | 2 |
| 2013 | 1 | 4 |
| 2014 | 2 | 4 |
| 2015 | 1 | 6 |
| 2016 | 1 | 4 |
| 2017 | 2 | 5 |
| 2018 | 3 | 11 |
| 2019 | 3 | 5 |
| 2020 | 4 | 6 |
| 2021 | 5 | 7 |
| 2022 | 4 | 6 |
| 2023 | 4 | 5 |
| 2024 | 0 | 2 |
| 2025 | 4 | 6 |
| 2026 | 1 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method and antibody for detection of HBcAg12 May 2026US 12,624,090 B2Xiamen Innodx Biotech Co., Ltd
- Kit of in vitro quantifying large surface protein of hepatitis B virus (HBV), biomarker set for analyzing phases of HBV infection and hepatoma prognosis, and set of monoclonal antibodies for predicting, diagnosing or treating chronic liver disease14 Oct 2025US 12,442,821 B2National Cheng Kung University
- Use of HLA-A*11:01-restricted hepatitis B virus (HBV) peptides for identifying HBV-specific CD8+ T cells16 Sep 2025US 12,414,990 B2Agency for Science, Technology and Research
- Anti-hepatitis B virus antibody and uses thereof9 Sep 2025US 12,410,239 B2Xiamen University
- HBV diagnostic, prognostic, and therapeutic methods and products25 Feb 2025US 12,235,273 B2Abbott Laboratories
- System and method for predicting or characterizing immune responses27 Aug 2026US 2026/0253746 A1Janssen Pharmaceutica NV
- Sensitizer for immunochromatographic measurements targeting hepatitis virus, specimen diluent for immunochromatographic measurements, immunochromatographic measurement method, tool for immunochromatographic measurements and test kit for hepatitis virus13 Aug 2026US 2026/0235611 A1Kawasaki Gakuen Educational Foundation
- Pharmaceutical composition that inhibits production of hepatitis b virus protein, pharmaceutical composition for treating hepatitis b, and screening method1 Jan 2026US 2026/0000699 A1FUJIFILM Corporation
- Affinity particle, test reagent, and detection method for detecting target immunoglobulin g in human specimen21 Aug 2025US 2025/0264472 A1Canon Kabushiki Kaisha
- Method for producing particle for immunoassay for detecting anti-hbs antibody, and particle obtained by the production method7 Aug 2025US 2025/0251398 A1Canon Kabushiki Kaisha
Most cited
By later US patents
- Solid-phase analytical device and method for using same173US 4,916,056 AAbbott Laboratories · 1990
- Method and apparatus for heterogeneous chemiluminescence assay146US 5,089,424 AAbbott Laboratories · 1992
- Solid-phase analytical device and method for using same142US 5,160,701 AAbbott Laboratories · 1992
- Method and composition for the simultaneous and discrete analysis of multiple analytes112US 5,567,627 ATrans-Med Biotech, Incorporated · 1996
- Process, device and reagent for cell separation97US 7,316,897 B2L'Assistance Publique, Hopitaux de Paris (AP-HP) · 2008